![](/img/cover-not-exists.png)
499 - Ifosfamide (IFO) in continuous infusion (C.I.) for 21 days as second line therapy in advanced sarcomas: A phase I study
A. Comandone, A. Boglione, O. Dal Canton, P. Bergnolo, C. Oliva, C. BummaVolume:
33
Year:
1997
Language:
english
DOI:
10.1016/s0959-8049(97)84994-5
File:
PDF, 222 KB
english, 1997